← FDA Drug Approvals (Drugs@FDA)
PACLITAXEL
NDA · New Drug Application · Sponsor: AM REGENT · Approved 2022-07-27
Drug application
- FDA Application #
NDA211875- Application type
- New Drug Application
- Brand name
- PACLITAXEL
- Generic name
- PACLITAXEL
- Active ingredients
- PACLITAXEL
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- AM REGENT
- Manufacturer
- American Regent, Inc.
- First approval
- 2022-07-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown